Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Brian D. Schilling"'
Autor:
Lindsay M. Henderson, Renee F. Robinson, Lily Ray, Burhan A. Khan, Tianran Li, Denise A. Dillard, Brian D. Schilling, Mike Mosley, Patricia L. Janssen, Alison E. Fohner, Allan E. Rettie, Kenneth E. Thummel, Timothy A. Thornton, David L. Veenstra
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 3, Pp 312-320 (2019)
Alaska Native and American Indian (AN/AI) people have unique pharmacogene variation that may affect warfarin disposition and therapeutic response. We performed targeted genotyping for cytochrome P450 (CYP)2C9, vitamin K epoxide oxidase reductase comp
Externí odkaz:
https://doaj.org/article/24dfd5d4d6b04ffdb379e9c74e4862ad
Autor:
Renee Robinson, Kenneth E. Thummel, Allan E. Rettie, Alison E. Fohner, Lily Ray, Burhan Khan, Timothy A. Thornton, Patricia L. Janssen, Mike Mosley, Lindsay M. Henderson, David L. Veenstra, Denise A. Dillard, Brian D. Schilling, Tianran Li
Publikováno v:
Clinical and Translational Science. 12:312-320
Alaska Native and American Indian (AN/AI) people have unique pharmacogene variation that may affect warfarin disposition and therapeutic response. We performed targeted genotyping for cytochrome P450 (CYP)2C9, vitamin K epoxide oxidase reductase comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb98f4eaaf83da4a707d15bd239088c5
https://doi.org/10.1111/cts.12611
https://doi.org/10.1111/cts.12611
Autor:
LeeAnna I. Muzquiz, Renee F. Robinson, Julie A. Beans, Holly Frydenlund, Burhan Khan, Kenneth E. Thummel, Matthew J. Olnes, Brian Phillips, Timothy A. Thornton, Cindi Laukes, Erica L. Woodahl, Brian D. Schilling, Denise A. Dillard, Laura Trawicki, Alison E. Fohner, Patrick Beatty, Deborah A. Nickerson, Kevin Howlett
Publikováno v:
Clinical and Translational Science. 11:312-321
Despite evidence that pharmacogenetics can improve tamoxifen pharmacotherapy, there are few studies with American Indian and Alaska Native (AIAN) people. We examined variation in cytochrome P450 (CYP) genes (CYP2D6, CYP3A4, CYP3A5, and CYP2C9) and ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::184cb9362f0c539e8b2e3d8a55f7b301
https://doi.org/10.1111/cts.12542
https://doi.org/10.1111/cts.12542
Autor:
Lindsay M, Henderson, Renee F, Robinson, Lily, Ray, Burhan A, Khan, Tianran, Li, Denise A, Dillard, Brian D, Schilling, Mike, Mosley, Patricia L, Janssen, Alison E, Fohner, Allan E, Rettie, Kenneth E, Thummel, Timothy A, Thornton, David L, Veenstra
Publikováno v:
Clinical and Translational Science
Alaska Native and American Indian (AN/AI) people have unique pharmacogene variation that may affect warfarin disposition and therapeutic response. We performed targeted genotyping for cytochrome P450 (CYP)2C9, vitamin K epoxide oxidase reductase comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::977889fc4b9cc4ae47dc05e0e59c7257
https://pubmed.ncbi.nlm.nih.gov/30821933
https://pubmed.ncbi.nlm.nih.gov/30821933
Autor:
Burhan A, Khan, Renee, Robinson, Alison E, Fohner, LeeAnna I, Muzquiz, Brian D, Schilling, Julie A, Beans, Matthew J, Olnes, Laura, Trawicki, Holly, Frydenlund, Cindi, Laukes, Patrick, Beatty, Brian, Phillips, Deborah, Nickerson, Kevin, Howlett, Denise A, Dillard, Timothy A, Thornton, Kenneth E, Thummel, Erica L, Woodahl
Publikováno v:
Clinical and Translational Science
Despite evidence that pharmacogenetics can improve tamoxifen pharmacotherapy, there are few studies with American Indian and Alaska Native (AIAN) people. We examined variation in cytochrome P450 (CYP) genes (CYP2D6, CYP3A4, CYP3A5, and CYP2C9) and ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab8f663bb686acf74cc9eb6878fdcd0f
https://pubmed.ncbi.nlm.nih.gov/29436156
https://pubmed.ncbi.nlm.nih.gov/29436156
Autor:
Adam S. Gordon, Bert B. Boyer, Scarlett E. Hopkins, Hemant K. Tiwari, Timothy A. Thornton, Kenneth E. Thummel, Jynene Black, Federico M. Farin, Alison E. Fohner, Jesse Tsai, Burhan Khan, Brian D. Schilling, Deborah A. Nickerson, Joseph M. Yracheta, Denise A. Dillard, Howard W. Wiener, Allan E. Rettie, Renee F. Robinson
Objectives Pharmacogenetic testing is projected to improve health outcomes and reduce the cost of care by increasing therapeutic efficacy and minimizing drug toxicity. American Indian and Alaska Native (AI/AN) people historically have been excluded f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04a270722d2994f338fc71e918951ce6
https://europepmc.org/articles/PMC4461509/
https://europepmc.org/articles/PMC4461509/
